---
figid: PMC7780023__CAS-112-31-g004
figtitle: 'TET2: A cornerstone in normal and malignant hematopoiesis'
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC7780023
filename: CAS-112-31-g004.jpg
figlink: pmc/articles/PMC7780023/figure/cas14688-fig-0004/
number: F4
caption: Inflammatory signals drive ten‐eleven translocation 2 (TET2) loss‐driven
  clonal expansion and preleukemic myeloproliferation.Tet2‐null hematopoietic stem/progenitor
  cells (HSPCs) show hyperactivation of interleukin‐6 (IL‐6)/Shp2/Stat3/Morrbid pathway,
  which reduces apoptosis and promotes cell survival, clonal expansion, and preleukemic
  myeloproliferation ofTet2‐deficient cells under basal conditions as well as inflammation.
  In addition, noncanonical nuclear factor‐κB signaling mediated by Toll‐like receptor
  (TLR)‐TRAF6‐A20 axis protectsTet2‐deficient HSPCs from chronic inflammation and
  drives competitive advantage of these cells in an inflammatory milieu. BM, bone
  marrow; LPS, lipopolysaccharide
papertitle: 'TET2: A cornerstone in normal and malignant hematopoiesis.'
reftext: Hiroyoshi Kunimoto, et al. Cancer Sci. 2021 Jan;112(1):31-40.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9447431
figid_alias: PMC7780023__F4
figtype: Figure
redirect_from: /figures/PMC7780023__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7780023__CAS-112-31-g004.html
  '@type': Dataset
  description: Inflammatory signals drive ten‐eleven translocation 2 (TET2) loss‐driven
    clonal expansion and preleukemic myeloproliferation.Tet2‐null hematopoietic stem/progenitor
    cells (HSPCs) show hyperactivation of interleukin‐6 (IL‐6)/Shp2/Stat3/Morrbid
    pathway, which reduces apoptosis and promotes cell survival, clonal expansion,
    and preleukemic myeloproliferation ofTet2‐deficient cells under basal conditions
    as well as inflammation. In addition, noncanonical nuclear factor‐κB signaling
    mediated by Toll‐like receptor (TLR)‐TRAF6‐A20 axis protectsTet2‐deficient HSPCs
    from chronic inflammation and drives competitive advantage of these cells in an
    inflammatory milieu. BM, bone marrow; LPS, lipopolysaccharide
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tlr4
  - Tet2
  - Il6
  - Ptpn11
  - Stat3
  - Traf6
  - Morrbid
  - Tnfaip3
  - Bcl2l11
  - Nfkb1
  - IRF6
  - TET2
  - IL6
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - PTPN11
  - STAT3
  - TRAF6
  - MIR4435-2HG
  - TNFAIP3
  - IGKV1-27
  - BCL2L11
  - NFKB1
  - PSMA7
  - tet2
  - il6
  - ptpn11a
  - stat3
  - traf6
  - bcl2l11
---
